| node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
| BRCA1 | E2F1 | ENSAMEP00000000197 | ENSAMEP00000009461 | Breast cancer type 1 susceptibility protein homolog; E3 ubiquitin-protein ligase that specifically mediates the formation of 'Lys-6'-linked polyubiquitin chains and plays a central role in DNA repair by facilitating cellular responses to DNA damage. It is unclear whether it also mediates the formation of other types of polyubiquitin chains. The E3 ubiquitin-protein ligase activity is required for its tumor suppressor function. The BRCA1-BARD1 heterodimer coordinates a diverse range of cellular pathways such as DNA damage repair, ubiquitination and transcriptional regulation to maintain [...] | E2F transcription factor 1. | 0.567 |
| BRCA1 | MYCN | ENSAMEP00000000197 | ENSAMEP00000001110 | Breast cancer type 1 susceptibility protein homolog; E3 ubiquitin-protein ligase that specifically mediates the formation of 'Lys-6'-linked polyubiquitin chains and plays a central role in DNA repair by facilitating cellular responses to DNA damage. It is unclear whether it also mediates the formation of other types of polyubiquitin chains. The E3 ubiquitin-protein ligase activity is required for its tumor suppressor function. The BRCA1-BARD1 heterodimer coordinates a diverse range of cellular pathways such as DNA damage repair, ubiquitination and transcriptional regulation to maintain [...] | MYCN proto-oncogene, bHLH transcription factor. | 0.615 |
| BRCA1 | SKP2 | ENSAMEP00000000197 | ENSAMEP00000013001 | Breast cancer type 1 susceptibility protein homolog; E3 ubiquitin-protein ligase that specifically mediates the formation of 'Lys-6'-linked polyubiquitin chains and plays a central role in DNA repair by facilitating cellular responses to DNA damage. It is unclear whether it also mediates the formation of other types of polyubiquitin chains. The E3 ubiquitin-protein ligase activity is required for its tumor suppressor function. The BRCA1-BARD1 heterodimer coordinates a diverse range of cellular pathways such as DNA damage repair, ubiquitination and transcriptional regulation to maintain [...] | S-phase kinase associated protein 2. | 0.407 |
| CDK9 | MYCN | ENSAMEP00000015868 | ENSAMEP00000001110 | Cyclin dependent kinase 9; Belongs to the protein kinase superfamily. | MYCN proto-oncogene, bHLH transcription factor. | 0.561 |
| CDK9 | SP1 | ENSAMEP00000015868 | ENSAMEP00000013144 | Cyclin dependent kinase 9; Belongs to the protein kinase superfamily. | Sp1 transcription factor. | 0.605 |
| E2F1 | BRCA1 | ENSAMEP00000009461 | ENSAMEP00000000197 | E2F transcription factor 1. | Breast cancer type 1 susceptibility protein homolog; E3 ubiquitin-protein ligase that specifically mediates the formation of 'Lys-6'-linked polyubiquitin chains and plays a central role in DNA repair by facilitating cellular responses to DNA damage. It is unclear whether it also mediates the formation of other types of polyubiquitin chains. The E3 ubiquitin-protein ligase activity is required for its tumor suppressor function. The BRCA1-BARD1 heterodimer coordinates a diverse range of cellular pathways such as DNA damage repair, ubiquitination and transcriptional regulation to maintain [...] | 0.567 |
| E2F1 | G1L923_AILME | ENSAMEP00000009461 | ENSAMEP00000003392 | E2F transcription factor 1. | Uncharacterized protein; Belongs to the SKP1 family. | 0.412 |
| E2F1 | MYCN | ENSAMEP00000009461 | ENSAMEP00000001110 | E2F transcription factor 1. | MYCN proto-oncogene, bHLH transcription factor. | 0.555 |
| E2F1 | SKP1 | ENSAMEP00000009461 | ENSAMEP00000018814 | E2F transcription factor 1. | S-phase kinase associated protein 1; Belongs to the SKP1 family. | 0.412 |
| E2F1 | SKP2 | ENSAMEP00000009461 | ENSAMEP00000013001 | E2F transcription factor 1. | S-phase kinase associated protein 2. | 0.838 |
| E2F1 | SP1 | ENSAMEP00000009461 | ENSAMEP00000013144 | E2F transcription factor 1. | Sp1 transcription factor. | 0.679 |
| E2F1 | TRRAP | ENSAMEP00000009461 | ENSAMEP00000007242 | E2F transcription factor 1. | Transformation/transcription domain associated protein; Belongs to the PI3/PI4-kinase family. | 0.441 |
| G1L923_AILME | E2F1 | ENSAMEP00000003392 | ENSAMEP00000009461 | Uncharacterized protein; Belongs to the SKP1 family. | E2F transcription factor 1. | 0.412 |
| G1L923_AILME | MYCN | ENSAMEP00000003392 | ENSAMEP00000001110 | Uncharacterized protein; Belongs to the SKP1 family. | MYCN proto-oncogene, bHLH transcription factor. | 0.576 |
| G1L923_AILME | SKP2 | ENSAMEP00000003392 | ENSAMEP00000013001 | Uncharacterized protein; Belongs to the SKP1 family. | S-phase kinase associated protein 2. | 0.984 |
| MAX | MYCN | ENSAMEP00000003654 | ENSAMEP00000001110 | MYC associated factor X. | MYCN proto-oncogene, bHLH transcription factor. | 0.909 |
| MAX | TRRAP | ENSAMEP00000003654 | ENSAMEP00000007242 | MYC associated factor X. | Transformation/transcription domain associated protein; Belongs to the PI3/PI4-kinase family. | 0.581 |
| MYCN | BRCA1 | ENSAMEP00000001110 | ENSAMEP00000000197 | MYCN proto-oncogene, bHLH transcription factor. | Breast cancer type 1 susceptibility protein homolog; E3 ubiquitin-protein ligase that specifically mediates the formation of 'Lys-6'-linked polyubiquitin chains and plays a central role in DNA repair by facilitating cellular responses to DNA damage. It is unclear whether it also mediates the formation of other types of polyubiquitin chains. The E3 ubiquitin-protein ligase activity is required for its tumor suppressor function. The BRCA1-BARD1 heterodimer coordinates a diverse range of cellular pathways such as DNA damage repair, ubiquitination and transcriptional regulation to maintain [...] | 0.615 |
| MYCN | CDK9 | ENSAMEP00000001110 | ENSAMEP00000015868 | MYCN proto-oncogene, bHLH transcription factor. | Cyclin dependent kinase 9; Belongs to the protein kinase superfamily. | 0.561 |
| MYCN | E2F1 | ENSAMEP00000001110 | ENSAMEP00000009461 | MYCN proto-oncogene, bHLH transcription factor. | E2F transcription factor 1. | 0.555 |